These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 5068023)

  • 21. [The effect of amantadine in parkinsonism: clinical and neurophysiological findings].
    Fünfgeld EW
    Dtsch Med Wochenschr; 1970 Sep; 95(36):1834-6. PubMed ID: 5453004
    [No Abstract]   [Full Text] [Related]  

  • 22. Syndrome of inappropriate antidiuretic hormone secretion possibly associated with amantadine therapy in Parkinson disease.
    Alonso Navarro H; Sánz-Aiz A; Izquierdo L; Jiménez Jiménez FJ
    Clin Neuropharmacol; 2009; 32(3):167-8. PubMed ID: 19483487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amantadine in Parkinson's disease: pro and contra.
    Greulich W; Fenger E
    J Neural Transm Suppl; 1995; 46():415-21. PubMed ID: 8821077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dopaminergic agents, COMT inhibitors or amantadine? Proper treatment for your Parkinson patient].
    Ceballos-Baumann AO
    MMW Fortschr Med; 2002 May; Suppl 2():37-43. PubMed ID: 12070848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of amantadine on the state of consciousness in diffuse cerebral psychosyndromes caused by vascular disorders].
    Vitetta M
    Minerva Med; 1971 Oct; 62(82):3984-6. PubMed ID: 5125059
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experience in the prolonged use of midantan (amantadine hydrochloride) in parkinsonism].
    Man'kovskii NB; Vainshtok AB; Oleinik LI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):524-30. PubMed ID: 4705407
    [No Abstract]   [Full Text] [Related]  

  • 27. Differentiation of tardive dyskinesias and drug-induced Parkinsonism.
    N Engl J Med; 1971 Jun; 284(24):1382-4. PubMed ID: 5576464
    [No Abstract]   [Full Text] [Related]  

  • 28. Twenty-five years of amantadine therapy in Parkinson's disease.
    Danielczyk W
    J Neural Transm Suppl; 1995; 46():399-405. PubMed ID: 8821075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Amantadine therapy in parkinsonism].
    Blomberg LH
    Lakartidningen; 1972 Nov; 69(46):5339. PubMed ID: 4650741
    [No Abstract]   [Full Text] [Related]  

  • 30. [Long-term therapy of the Parkinson syndrome].
    Ludin HP
    Schweiz Med Wochenschr; 1984 Aug; 114(33):1131-6. PubMed ID: 6484543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticholinergic syndrome with severe rhabdomyolysis--an unusual feature of amantadine toxicity.
    Yang CC; Deng JF
    Intensive Care Med; 1997 Mar; 23(3):355-6. PubMed ID: 9083247
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effects of amantadine therapy on sleep spindles in patients with parkinsonism and comparative analysis of L-dopa effects].
    Puca FM; Pigneri MT
    Boll Soc Ital Biol Sper; 1972 May; 48(9):237-40. PubMed ID: 5070096
    [No Abstract]   [Full Text] [Related]  

  • 33. Amantadine-induced livedo reticularis: a report of two cases.
    Hayes BB; Cook-Norris RH; Miller JL; Rodriguez A; Zic JA
    J Drugs Dermatol; 2006 Mar; 5(3):288-9. PubMed ID: 16573266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Amantadine in the treatment of transitory hypokinesia in patients with parkinsonism during therapy with L-Dopa].
    De Divitiis E; D'Andrea F; Signorelli CD; Cerillo A
    Minerva Med; 1971 Oct; 62(82):4007-8. PubMed ID: 5125065
    [No Abstract]   [Full Text] [Related]  

  • 35. [Drug therapy of parkinsonism].
    Teräväinen H; Larsen TA
    Duodecim; 1982; 98(11):892-900. PubMed ID: 6125373
    [No Abstract]   [Full Text] [Related]  

  • 36. Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine: report of a case series.
    Singer C; Papapetropoulos S; Gonzalez MA; Roberts EL; Lieberman A
    Mov Disord; 2005 Jul; 20(7):873-7. PubMed ID: 15809995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vascular hemi-parkinson disease].
    Tison F; Duché B; Loiseau P
    Rev Neurol (Paris); 1993; 149(10):565-7. PubMed ID: 8023073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride.
    Reveno WS; Bauer RB; Rosenbaum H
    Geriatrics; 1971 Aug; 26(8):61-70. PubMed ID: 5096462
    [No Abstract]   [Full Text] [Related]  

  • 39. [On some effects of amantadine in muscle potentials in parkinsonism].
    Laterza A; Jandolo B; Sinibaldi L
    Minerva Med; 1971 Oct; 62(82):3987-9. PubMed ID: 5125060
    [No Abstract]   [Full Text] [Related]  

  • 40. Livedo reticularis in patients with parkinsonism receiving amantadine.
    Shealy CN; Weeth JB; Mercier D
    JAMA; 1970 Jun; 212(9):1522-3. PubMed ID: 5467552
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.